CYPH

CYPH · Cypherpunk Technologies Inc. Common Stock

View on chart

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 29, 2026

CYPH in Spotlight as Smaller Health Care Names Outperform. Recent coverage noted that smaller health‑care names outperformed larger peers, and CYPH is among those that could benefit from the sector’s momentum. The same report highlighted significant whale activity in health‑care stocks, suggesting growing institutional interest. These developments may affect CYPH’s trading dynamics. No specific price guidance is provided.

this person other insiders at CYPH

Insiders & Stakes

Winklevoss Capital Fund, LLC24,854,613
Shares held
McEvoy William Patrick III
Chief Investment Officer
24,854,613
Shares held
BeiGene, Ltd.
10% Owner
7,348,437
Shares held
James H. Cavanaugh
Director
168,963
Shares held
William Li
Director
168,750
Shares held
Christian M. Richard
Director
168,750
Shares held
Nissim Mashiach
Director
168,750
Shares held
Richard Schilsky
Director
168,750
Shares held
Joseph Loscalzo
Director
168,750
Shares held
Thomas John Dietz
Director
132,500
Shares held
Christopher Mirabelli
Chairman of the Board
130,376
Shares held
Patricia A. Martin
Director
118,750
Shares held
Douglas E. Onsi
CEO,CFO,Pres.,GC,Treas.,&Sec.
106,858
Shares held
O'Mahony John Mark
Chief Manufacturing Officer
27,500
Shares held
Sirard Cynthia
Chief Medical Officer
27,500
Shares held
LAWLOR AUGUSTINE
Director
19,789
Shares held
Granfield Christine
VP, Head of Reg Affairs/Qual
15,896
Shares held
Baum Jason
Chief Scientific Officer
15,896
Shares held
Khing Djien Oei
Director
0
Shares held

Transaction History

Khing Djien Oei▼ Sell$662K
Patricia A. Martin▼ Sell$193K
Thomas John Dietz▼ Sell$34K
Winklevoss Capital Fund, LLC▼ Sell$17K
McEvoy William Patrick III▼ Sell$17K
Christopher Mirabelli▼ Sell$43K
Richard Schilsky▲ Buy—
Thomas John Dietz▲ Buy—
Christopher Mirabelli▲ Buy—
Christopher Mirabelli▲ Buy—
Khing Djien Oei▲ Buy—
Khing Djien Oei▲ Buy—
William Li▲ Buy—
William Li▲ Buy—
Christian M. Richard▲ Buy—
Christian M. Richard▲ Buy—
Nissim Mashiach▲ Buy—
Nissim Mashiach▲ Buy—
Patricia A. Martin▲ Buy—
Patricia A. Martin▲ Buy—
Richard Schilsky▲ Buy—
Joseph Loscalzo▲ Buy—
Joseph Loscalzo▲ Buy—
James H. Cavanaugh▲ Buy—
James H. Cavanaugh▲ Buy—
Thomas John Dietz▲ Buy—
Thomas John Dietz▼ Sell$42K
Christopher Mirabelli▼ Sell$0
Christopher Mirabelli▼ Sell$0
Douglas E. Onsi▼ Sell$0
Douglas E. Onsi▼ Sell$0
Christopher Mirabelli▼ Sell$822K
Christopher Mirabelli▼ Sell$1.3M
James H. Cavanaugh▼ Sell$822K
Douglas E. Onsi▼ Sell$822K
Douglas E. Onsi▼ Sell$1.3M
Sirard Cynthia▲ Buy—
Douglas E. Onsi▲ Buy—
Granfield Christine▲ Buy—
Granfield Christine▼ Sell$2K
Baum Jason▲ Buy—
Baum Jason▼ Sell$2K
LAWLOR AUGUSTINE▲ Buy—
LAWLOR AUGUSTINE▼ Sell$2K
O'Mahony John Mark▲ Buy—
Christopher Mirabelli▲ Buy—
Christopher Mirabelli▼ Sell$2K
Christopher Mirabelli▼ Sell$6K
James H. Cavanaugh▼ Sell$601
Douglas E. Onsi▼ Sell$6K
LAWLOR AUGUSTINE▼ Sell$6K
Sirard Cynthia▲ Buy—
LAWLOR AUGUSTINE▲ Buy—
O'Mahony John Mark▲ Buy—
Douglas E. Onsi▲ Buy—
Christopher Mirabelli▲ Buy—
Douglas E. Onsi▲ Buy—
BeiGene, Ltd.▲ Buy$7.2M

We use analytics to understand how market-wall is used. No personal data is sold.